KORNFIELD, Rachel; WATSON, Sydeaka; HIGASHI, Ashley S. Effects of FDA Advisories on the Pharmacologic Treatment of ADHD, 2004–2008. Psychiatric Services. 2013-04, roč. 64, čís. 4, s. 339–346. Dostupné online [cit. 2025-01-26]. ISSN1075-2730. doi:10.1176/appi.ps.201200147. PMID23318985.
VAN ZWIETEN, P.A.; THOOLEN, M.J.M.C.; TIMMERMANS, P.B.M.W.M. THE PHARMACOLOGY OF CENTRALLY ACTING ANTIHYPERTENSIVE DRUGS. British Journal of Clinical Pharmacology. 1983-12, roč. 15, čís. Supplement s4. Dostupné online [cit. 2025-01-26]. ISSN0306-5251. doi:10.1111/j.1365-2125.1983.tb00311.x. (anglicky)
ARNSTEN, Amy F. T.; RASKIND, Murray A.; TAYLOR, Fletcher B. The effects of stress exposure on prefrontal cortex: Translating basic research into successful treatments for post-traumatic stress disorder. Neurobiology of Stress. 2015-01-01, roč. 1, čís. Stress Resilience, s. 89–99. Dostupné online [cit. 2025-01-26]. ISSN2352-2895. doi:10.1016/j.ynstr.2014.10.002. PMID25436222.
CLEMOW, David B.; WALKER, Daniel J. The Potential for Misuse and Abuse of Medications in ADHD: A Review. Postgraduate Medicine. 2014-09-01, roč. 126, čís. 5, s. 64–81. PMID: 25295651. Dostupné online [cit. 2025-01-26]. ISSN0032-5481. doi:10.3810/pgm.2014.09.2801. PMID25295651.
MCKEE, Sherry A; POTENZA, Marc N; KOBER, Hedy. A translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessation. Journal of Psychopharmacology. 2015-03-01, roč. 29, čís. 3, s. 300–311. Dostupné online [cit. 2025-01-26]. ISSN0269-8811. doi:10.1177/0269881114562091. PMID25516371. (anglicky)
CATALÁ-LÓPEZ, Ferrán; HUTTON, Brian; NÚÑEZ-BELTRÁN, Amparo. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. PLOS ONE. 12. 7. 2017, roč. 12, čís. 7, s. e0180355. Dostupné online [cit. 2025-01-26]. ISSN1932-6203. doi:10.1371/journal.pone.0180355. PMID28700715. (anglicky)
JERIE, P. Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine.. British Journal of Clinical Pharmacology. 1980, roč. 10, čís. S1, s. 157S–164S. Dostupné online [cit. 2025-01-26]. ISSN1365-2125. doi:10.1111/j.1365-2125.1980.tb04924.x. PMID6994770. (anglicky)
RUGINO, Thomas A. Effect on Primary Sleep Disorders When Children With ADHD Are Administered Guanfacine Extended Release. Journal of Attention Disorders. 2018-01-01, roč. 22, čís. 1, s. 14–24. Dostupné online [cit. 2025-01-26]. ISSN1087-0547. doi:10.1177/1087054714554932. (anglicky)
Guanfacine Monograph for Professionals - Drugs.com. web.archive.org [online]. 2018-01-15 [cit. 2025-01-26]. Dostupné v archivu pořízeném z originálu dne 2018-01-15.
ARNSTEN, Amy F. T.; RASKIND, Murray A.; TAYLOR, Fletcher B. The effects of stress exposure on prefrontal cortex: Translating basic research into successful treatments for post-traumatic stress disorder. Neurobiology of Stress. 2015-01-01, roč. 1, čís. Stress Resilience, s. 89–99. Dostupné online [cit. 2025-01-26]. ISSN2352-2895. doi:10.1016/j.ynstr.2014.10.002. PMID25436222.
IJEST. A Comprehensive Literature Review on Guanfacine as a Potential Treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). https://www.ijest.org/ [online]. 2023-05-01 [cit. 2025-01-26]. Dostupné online. (anglicky)
KORNFIELD, Rachel; WATSON, Sydeaka; HIGASHI, Ashley S. Effects of FDA Advisories on the Pharmacologic Treatment of ADHD, 2004–2008. Psychiatric Services. 2013-04, roč. 64, čís. 4, s. 339–346. Dostupné online [cit. 2025-01-26]. ISSN1075-2730. doi:10.1176/appi.ps.201200147. PMID23318985.
ARNSTEN, Amy F. T.; RASKIND, Murray A.; TAYLOR, Fletcher B. The effects of stress exposure on prefrontal cortex: Translating basic research into successful treatments for post-traumatic stress disorder. Neurobiology of Stress. 2015-01-01, roč. 1, čís. Stress Resilience, s. 89–99. Dostupné online [cit. 2025-01-26]. ISSN2352-2895. doi:10.1016/j.ynstr.2014.10.002. PMID25436222.
CLEMOW, David B.; WALKER, Daniel J. The Potential for Misuse and Abuse of Medications in ADHD: A Review. Postgraduate Medicine. 2014-09-01, roč. 126, čís. 5, s. 64–81. PMID: 25295651. Dostupné online [cit. 2025-01-26]. ISSN0032-5481. doi:10.3810/pgm.2014.09.2801. PMID25295651.
MCKEE, Sherry A; POTENZA, Marc N; KOBER, Hedy. A translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessation. Journal of Psychopharmacology. 2015-03-01, roč. 29, čís. 3, s. 300–311. Dostupné online [cit. 2025-01-26]. ISSN0269-8811. doi:10.1177/0269881114562091. PMID25516371. (anglicky)
CATALÁ-LÓPEZ, Ferrán; HUTTON, Brian; NÚÑEZ-BELTRÁN, Amparo. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. PLOS ONE. 12. 7. 2017, roč. 12, čís. 7, s. e0180355. Dostupné online [cit. 2025-01-26]. ISSN1932-6203. doi:10.1371/journal.pone.0180355. PMID28700715. (anglicky)
JERIE, P. Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine.. British Journal of Clinical Pharmacology. 1980, roč. 10, čís. S1, s. 157S–164S. Dostupné online [cit. 2025-01-26]. ISSN1365-2125. doi:10.1111/j.1365-2125.1980.tb04924.x. PMID6994770. (anglicky)
CATALÁ-LÓPEZ, Ferrán; HUTTON, Brian; NÚÑEZ-BELTRÁN, Amparo. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. PLOS ONE. 12. 7. 2017, roč. 12, čís. 7, s. e0180355. Dostupné online [cit. 2025-01-26]. ISSN1932-6203. doi:10.1371/journal.pone.0180355. PMID28700715. (anglicky)
KORNFIELD, Rachel; WATSON, Sydeaka; HIGASHI, Ashley S. Effects of FDA Advisories on the Pharmacologic Treatment of ADHD, 2004–2008. Psychiatric Services. 2013-04, roč. 64, čís. 4, s. 339–346. Dostupné online [cit. 2025-01-26]. ISSN1075-2730. doi:10.1176/appi.ps.201200147. PMID23318985.
MCKEE, Sherry A; POTENZA, Marc N; KOBER, Hedy. A translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessation. Journal of Psychopharmacology. 2015-03-01, roč. 29, čís. 3, s. 300–311. Dostupné online [cit. 2025-01-26]. ISSN0269-8811. doi:10.1177/0269881114562091. PMID25516371. (anglicky)
RUGINO, Thomas A. Effect on Primary Sleep Disorders When Children With ADHD Are Administered Guanfacine Extended Release. Journal of Attention Disorders. 2018-01-01, roč. 22, čís. 1, s. 14–24. Dostupné online [cit. 2025-01-26]. ISSN1087-0547. doi:10.1177/1087054714554932. (anglicky)
CLEMOW, David B.; WALKER, Daniel J. The Potential for Misuse and Abuse of Medications in ADHD: A Review. Postgraduate Medicine. 2014-09-01, roč. 126, čís. 5, s. 64–81. PMID: 25295651. Dostupné online [cit. 2025-01-26]. ISSN0032-5481. doi:10.3810/pgm.2014.09.2801. PMID25295651.
Guanfacine Monograph for Professionals - Drugs.com. web.archive.org [online]. 2018-01-15 [cit. 2025-01-26]. Dostupné v archivu pořízeném z originálu dne 2018-01-15.
Intuniv 1 mg, 2 mg, 3 mg, 4 mg prolonged-release tablets - - (eMC). web.archive.org [online]. 2018-01-15 [cit. 2025-01-26]. Dostupné v archivu pořízeném z originálu dne 2018-01-15.
VAN ZWIETEN, P.A.; THOOLEN, M.J.M.C.; TIMMERMANS, P.B.M.W.M. THE PHARMACOLOGY OF CENTRALLY ACTING ANTIHYPERTENSIVE DRUGS. British Journal of Clinical Pharmacology. 1983-12, roč. 15, čís. Supplement s4. Dostupné online [cit. 2025-01-26]. ISSN0306-5251. doi:10.1111/j.1365-2125.1983.tb00311.x. (anglicky)
JERIE, P. Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine.. British Journal of Clinical Pharmacology. 1980, roč. 10, čís. S1, s. 157S–164S. Dostupné online [cit. 2025-01-26]. ISSN1365-2125. doi:10.1111/j.1365-2125.1980.tb04924.x. PMID6994770. (anglicky)
KORNFIELD, Rachel; WATSON, Sydeaka; HIGASHI, Ashley S. Effects of FDA Advisories on the Pharmacologic Treatment of ADHD, 2004–2008. Psychiatric Services. 2013-04, roč. 64, čís. 4, s. 339–346. Dostupné online [cit. 2025-01-26]. ISSN1075-2730. doi:10.1176/appi.ps.201200147. PMID23318985.
VAN ZWIETEN, P.A.; THOOLEN, M.J.M.C.; TIMMERMANS, P.B.M.W.M. THE PHARMACOLOGY OF CENTRALLY ACTING ANTIHYPERTENSIVE DRUGS. British Journal of Clinical Pharmacology. 1983-12, roč. 15, čís. Supplement s4. Dostupné online [cit. 2025-01-26]. ISSN0306-5251. doi:10.1111/j.1365-2125.1983.tb00311.x. (anglicky)
ARNSTEN, Amy F. T.; RASKIND, Murray A.; TAYLOR, Fletcher B. The effects of stress exposure on prefrontal cortex: Translating basic research into successful treatments for post-traumatic stress disorder. Neurobiology of Stress. 2015-01-01, roč. 1, čís. Stress Resilience, s. 89–99. Dostupné online [cit. 2025-01-26]. ISSN2352-2895. doi:10.1016/j.ynstr.2014.10.002. PMID25436222.
CLEMOW, David B.; WALKER, Daniel J. The Potential for Misuse and Abuse of Medications in ADHD: A Review. Postgraduate Medicine. 2014-09-01, roč. 126, čís. 5, s. 64–81. PMID: 25295651. Dostupné online [cit. 2025-01-26]. ISSN0032-5481. doi:10.3810/pgm.2014.09.2801. PMID25295651.
MCKEE, Sherry A; POTENZA, Marc N; KOBER, Hedy. A translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessation. Journal of Psychopharmacology. 2015-03-01, roč. 29, čís. 3, s. 300–311. Dostupné online [cit. 2025-01-26]. ISSN0269-8811. doi:10.1177/0269881114562091. PMID25516371. (anglicky)
CATALÁ-LÓPEZ, Ferrán; HUTTON, Brian; NÚÑEZ-BELTRÁN, Amparo. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. PLOS ONE. 12. 7. 2017, roč. 12, čís. 7, s. e0180355. Dostupné online [cit. 2025-01-26]. ISSN1932-6203. doi:10.1371/journal.pone.0180355. PMID28700715. (anglicky)
JERIE, P. Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine.. British Journal of Clinical Pharmacology. 1980, roč. 10, čís. S1, s. 157S–164S. Dostupné online [cit. 2025-01-26]. ISSN1365-2125. doi:10.1111/j.1365-2125.1980.tb04924.x. PMID6994770. (anglicky)
RUGINO, Thomas A. Effect on Primary Sleep Disorders When Children With ADHD Are Administered Guanfacine Extended Release. Journal of Attention Disorders. 2018-01-01, roč. 22, čís. 1, s. 14–24. Dostupné online [cit. 2025-01-26]. ISSN1087-0547. doi:10.1177/1087054714554932. (anglicky)